Latest news
Loading news…
Capstan Therapeutics develops in vivo mRNA and gene-editing medicines for a broad range of diseases.
Capstan Therapeutics was acquired by AbbVie in 2025 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
63
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Diego, California, United States
Key People at Capstan Therapeutics
Director
Chief Medical Officer
Chief Technology Officer
Chief Business Officer
General Counsel
63
professional contacts at Capstan Therapeutics
Contact execs at Capstan Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Capstan Therapeutics
Loading news…
FAQs about Capstan Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.